These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7057383)

  • 1. Contribution of lungs to total body clearance: linear and nonlinear effects.
    Collins JM; Dedrick RL
    J Pharm Sci; 1982 Jan; 71(1):66-70. PubMed ID: 7057383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of apparent systemic clearance to individual organ clearances: effect of pulmonary clearance and site of drug administration and measurement.
    Mehvar R
    Pharm Res; 1991 Mar; 8(3):306-12. PubMed ID: 2052516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the lung in total body clearance of circulating drugs.
    Roth RA; Wiersma DA
    Clin Pharmacokinet; 1979; 4(5):355-67. PubMed ID: 41661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The physiological significance of total body clearance in pharmacokinetic studies.
    Chiou WL
    J Clin Hosp Pharm; 1982 Mar; 7(1):25-30. PubMed ID: 7096575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between steady state blood concentrations and cardiac output during intravenous infusions.
    Upton RN
    Biopharm Drug Dispos; 2000 Mar; 21(2):69-76. PubMed ID: 11100908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemistry, physiology and drug metabolism--implications regarding the role of the lungs in drug disposition.
    Roth RA
    Clin Physiol Biochem; 1985; 3(2-3):66-79. PubMed ID: 3891197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model independent derivation of general equations for the "first-pass" effect and extra-hepatic drug elimination.
    Vaughan
    Eur J Clin Pharmacol; 1977; 11(1):57-64. PubMed ID: 832659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic aspects of drug disposition in the lungs.
    Upton RN; Doolette DJ
    Clin Exp Pharmacol Physiol; 1999; 26(5-6):381-91. PubMed ID: 10386226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary: a physiological approach to hepatic drug clearance.
    Wilkinson GR; Shand DG
    Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conceptual underestimation of the total body clearance by the sum of clearances of individual organs in physiologically based pharmacokinetics.
    Berezhkovskiy LM
    J Pharm Sci; 2012 Dec; 101(12):4660-5. PubMed ID: 23001916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linear and nonlinear kinetics of drug elimination. I. Kinetics on the basis of a single capacity-limited pathway of elimination with or without simultaneous supply-limited elimination.
    van Ginneken CA; van Rossum JM; Fleuren HL
    J Pharmacokinet Biopharm; 1974 Oct; 2(5):395-415. PubMed ID: 4452943
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics in renal disease.
    Levy G
    Am J Med; 1977 Apr; 62(4):461-5. PubMed ID: 851113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kinetics.
    Rubin GM; Tozer TN
    J Pharmacokinet Biopharm; 1984 Aug; 12(4):437-50. PubMed ID: 6527233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. II. Clearance concepts applied to the evaluation of distribution kinetics.
    Gillespie WR; Veng-Pedersen P
    J Pharmacokinet Biopharm; 1985 Aug; 13(4):441-51. PubMed ID: 4087171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total body clearance of circulating benzo(a)pyrene in conscious rats: effect of pretreatment with 3-methylcholanthrene and the role of liver and lung.
    Wiersma DA; Roth RA
    J Pharmacol Exp Ther; 1983 Sep; 226(3):661-7. PubMed ID: 6310077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological determinants of altered pharmacokinetics in the elderly.
    Shand DG
    Gerontology; 1982; 28 Suppl 1():8-17. PubMed ID: 7044905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein binding and drug clearance.
    Rowland M
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():10-7. PubMed ID: 6705422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new model-independent physiological approach to study hepatic drug clearance and its applications.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential pitfalls in the conventional pharmacokinetic studies: effects of the initial mixing of drug in blood and the pulmonary first-pass elimination.
    Chiou WL
    J Pharmacokinet Biopharm; 1979 Oct; 7(5):527-36. PubMed ID: 529021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of whole-body metabolic clearance of drugs through the combined use of slices from rat liver, lung, kidney, small intestine and colon.
    De Kanter R; Monshouwer M; Draaisma AL; De Jager MH; de Graaf IA; Proost JH; Meijer DK; Groothuis GM
    Xenobiotica; 2004 Mar; 34(3):229-41. PubMed ID: 15204696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.